Cloud Banner

Pharmaceutical

Image

Global Inherited Retinal Diseases Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Inherited Retinal Diseases Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR - 7.9% Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 20154.18 Million
Diagram Market Size (Forecast Year) USD 37028.54 Million
Diagram CAGR 7.9%

Global Inherited Retinal Diseases Market, By Disease Type (Retinitis Pigmentosa, Stargardt’s Disease, Achromatopsia, Cone-Rod Dystrophy, Choroideremia, Leber Congenital Amaurosis, Macular Edema, Others), Type (Diagnosis, Therapy), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Others), Distribution Channel (Retail Sales, Direct Tender) – Industry Trends and Forecast to 2031.

Inherited Retinal Diseases Market Analysis and Size

As per the recent data Retinitis pigmentosa (RP), a group of inherited retinal diseases characterized by progressive degeneration of the retina has an incidence rate estimated to be around 1 in 3,500 to 1 in 4,000 individuals. Also, Retinoblastoma, a rare form of eye cancer that primarily affects children has an incidence rate estimated to be around 1 in 15,000 to 1 in 20,000 live births.

Data Bridge Market Research analyzes that the global inherited retinal diseases market which was USD 20,154.18 million in 2023, is likely to reach USD 37,028.54 million by 2031, and is expected to undergo a CAGR of 7.9% during the forecast period. “Diagnosis” dominates the type segment of the market due to the growing demand for better methods for treatment and diagnosis in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, and Pricing in USD

Segments Covered

By Disease Type (Retinitis Pigmentosa, Stargardt’s Disease, Achromatopsia, Cone-Rod Dystrophy, Choroideremia, Leber Congenital Amaurosis, Macular Edema, Others), Type (Diagnosis, Therapy), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Others), Distribution Channel (Retail Sales, Direct Tender)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa

Market Players Covered

Spark Therapeutics (U.S.), Novartis AG (Switzerland), Okuvision (Germany), Nidek Co. Ltd. (Japan), Invitae Corporation (U.S.), Carl Zeiss Meditech AG (Germany), Optos (A Subdidiary of Nikon Corporation) (U.K.), Neurosoft (Russia), PIXIUM VISION (France), LKC TECHNOLOGIES, INC. (U.S.), Renurone (U.K.), Astellas Pharma (Japan), REGENXBIO Inc. (U.S.), Ionis Pharmaceutics (U.S.), Sparing Vision (France), Ocugen Inc (U.S.), Johnson & Johnson (U.S.), IVERIC bio (U.S.), Second Sight (U.S.), Coave Therapeutics (U.S.), MeiraGTx Limited (U.K.), Gensight Biologics (France), ProQR Therapeutics (Netherlands), Bionic Vision Technologies (Australia)

Market Opportunities

  • Increasing awareness and diagnosis
  • Expansion of treatment options

Market Definition

Inherited retinal diseases-or IRDs-are a group of diseases that can cause severe vision loss or even blindness. Each IRD is caused by at least one gene that is not working as it should. IRDs can affect individuals of all ages, can progress at different rates, and are rare. However, many are degenerative, which means that the symptoms of the disease will get worse over time. Common types of IRDs include Leber Congenital Amaurosis (LCA), Retinitis Pigmentosa, Choroideremia, Stargardt’s Disease, and Achromatopsia.

Global  Inherited Retinal Diseases Market Dynamics

Drivers

  • Increase in the Prevalence of Inherited Retinal Diseases

The increasing prevalence and continuous discovery of new mutagenic sites that are genetically transmitted are expected to act as a driver for the growth of the market. The prevalence of monogenic IRDs is approximately 1 in 2000, affecting two million people online.

  • Increasing in Pipeline Products

As clinical trial activity rises to new levels, the field appears poised to make rapid and important advances in IRD research and patient care. These are only a few common trials, thus, the companies operating in this market continuously do clinical trials and put their candidates in clinical trials. This is expected to create an opportunity and fuel the inherited retinal diseases market. High prevalence of genetic conditions.

Opportunities

  • Increasing awareness and diagnosis

With growing awareness among healthcare professionals and patients, there is an opportunity to improve the diagnosis rate of IRDs. Early detection and diagnosis can lead to timely intervention and management of these diseases, potentially improving patient outcomes.

  • Expansion of treatment options

The IRD market has the opportunity to expand the range of treatment options available. Besides gene therapy, other approaches such as stem cell therapy, pharmacological interventions, and retinal implants are being explored. Advancements in these areas can provide additional treatment options for patients with IRDs.

Restraints/Challenges

  • High treatment cost

The cost of treatment for IRDs can be a significant restraint for patients and healthcare systems. Innovative therapies such as gene therapy can be expensive, making them inaccessible to a large portion of the population. The high cost of treatment can limit patient access and pose financial challenges for healthcare providers and payers.

  • Limited awareness and diagnostic challenges

Despite advancements in understanding and diagnosing IRDs, there is still a lack of awareness among healthcare professionals and the general public. This can lead to delayed or missed diagnoses, preventing timely intervention and management of these diseases. Additionally, diagnosing IRDs can be challenging due to the wide range of genetic mutations and phenotypic variability associated with these diseases. Improving awareness and diagnostic capabilities are essential challenges that need to be addressed in the IRD market.

This inherited retinal diseases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the inherited retinal diseases market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In January 2022, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation Enhanced Translational Research Acceleration Program

Global Inherited Retinal Diseases Market Scope

The inherited retinal diseases market is segmented on the basis of disease type, type, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

  • Retinitis Pigmentosa
  •  Stargardt’s Disease
  •  Achromatopsia
  •  Cone-Rod Dystrophy
  •  Choroideremia
  •  Leber Congenital Amaurosis (LCA)
  •  Macular Edema
  •  Others

Type

  • Diagnosis
  • Therapy

End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory surgical center
  • Home Healthcare
  • Others

Distribution Channel

  • Retail Sales
  • Direct Tender

Global Inherited Retinal Diseases Market Regional Analysis/Insights

The inherited retinal diseases market is analysed and market size insights and trends are provided by country, disease type, type, end-users and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and rest of Middle East & Africa.

North America is expected to dominate the market due to the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having genetic eye diseases.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The inherited retinal diseases market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the inherited retinal diseases market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the inherited retinal diseases market.

Competitive Landscape and Inherited Retinal Diseases  Market Share Analysis

The inherited retinal diseases market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the inherited retinal diseases market.

Some of the major players operating in the inherited retinal diseases market are:

  • Spark Therapeutics (U.S.)
  • Novartis AG (Switzerland)
  • Okuvision (Germany)
  • Nidek Co. Ltd. (Japan)
  • Invitae Corporation (U.S.)
  • Carl Zeiss Meditech AG (Germany)
  • Optos (A Subdidiary of Nikon Corporation) (U.K.)
  • Neurosoft (Russia)
  • PIXIUM VISION (France)
  • LKC TECHNOLOGIES, INC. (U.S.)
  • Renurone (U.K.)
  • Astellas Pharma (Japan)
  • REGENXBIO Inc. (U.S.)
  • Ionis Pharmaceutics (U.S.)
  • Sparing Vision (France)
  • Ocugen Inc (U.S.)
  • Johnson & Johnson (U.S.)
  • IVERIC bio (U.S.)
  • Second Sight (U.S.)
  • Coave Therapeutics (U.S.)
  • MeiraGTx Limited (U.K.)
  • Gensight Biologics (France)
  • ProQR Therapeutics (Netherlands)
  • Bionic Vision Technologies (Australia)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The inherited retinal diseases market size will be worth USD 37,028.54 million by 2031.
The growth rate of the inherited retinal diseases market is 7.9% in the forecast by 2031.
An increase in the prevalence of inherited retinal diseases & increasing in pipeline products are the growth drivers of the inherited retinal diseases market.
Disease type, type, end-users, and distribution channel are the factors on which the inherited retinal diseases market research is based.
Major companies in the inherited retinal diseases market are Spark Therapeutics (U.S.), Novartis AG (Switzerland), Okuvision (Germany), Nidek Co. Ltd. (Japan), Invitae Corporation (U.S.), Carl Zeiss Meditech AG (Germany), Optos (A Subdidiary of Nikon Corporation) (U.K.), Neurosoft (Russia), PIXIUM VISION (France), LKC TECHNOLOGIES, INC. (U.S.), Renurone (U.K.), Astellas Pharma (Japan), REGENXBIO Inc. (U.S.), Ionis Pharmaceutics (U.S.), Sparing Vision (France), Ocugen Inc (U.S.), Johnson & Johnson (U.S.), IVERIC bio (U.S.), Second Sight (U.S.), Coave Therapeutics (U.S.), MeiraGTx Limited (U.K.), Gensight Biologics (France), ProQR Therapeutics (Netherlands), Bionic Vision Technologies (Australia).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials